Soumitra Chatterjee undergoes dialysis in Kolkata hospital; actor's condition 'very critical', say doctors
Soumita Chatterjee was admitted to hospital on 6 October after he tested positive for COVID-19.
Doctors on Wednesday conducted the first round of dialysis on iconic Bengali actor Soumitra Chatterjee, as his health condition continued to be "very critical", officials at a Kolkata private hospital, where the thespian is undergoing treatment, said on Wednesday.
The 85-year old has been "unconscious" since last week.
"The first session of dialysis on Mr Chatterjee was successful and there were no episodes of blood pressure fluctuations. The dialysis normalised most of his health parameters and other renal functions. However, his condition remains very critical," a doctor at the medical facility said.
The acclaimed actor's consciousness-level is still "critical", though he had no fresh bout of fever. He is also suffering from secondary pneumonia. His lung functions are more or less stable and his ventilation parameter is also good, doctors said.
Chatterjee, the first Indian film personality to be awarded the Ordre des Arts et des Lettres — France's highest civilian award — was admitted to hospital on 6 October after he tested positive for COVID-19 .
Nushrratt Bharuccha on bagging her first solo project, Chhorii and how it's a 'socially responsible horror film'
Nushrratt Bharuccha says Chhorii is a horror film with perspective: "It’s communicating a social evil, something we should take cognisance of and bring a change"
Aayush Sharma on playing a grey character in Antim, working with Salman Khan: 'It's a big responsibility'
Aayush Sharma on Antim: "The first time that I looked into Salman Bhai’s eyes in front of the camera, I froze. He is the star I have grown up watching and now I was in the same frame as him”
Abhimanyu Dassani reacts to Meenakshi Sundareshwar controversy: 'No one tries to make a film to insult anyone'
Abhimanyu Dassani deconstructs his character from Meenakshi Sundareshwar, reacts to the film's controversy, and discusses upcoming projects.